Total Payments
$85,507
2024 Payments
$2,659
Companies
52
Transactions
752
Medicare Patients
13,301
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$67,050 (78.4%)
Food & Beverage$14,575 (17.0%)
Travel$3,666 (4.3%)
Education$216.30 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $67,025 | 27 | 78.4% |
| Food and Beverage | $14,575 | 696 | 17.0% |
| Travel and Lodging | $3,666 | 19 | 4.3% |
| Education | $216.30 | 9 | 0.3% |
| Entertainment | $25.11 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $46,869 | 123 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $25,970 | 110 | $0 (2024) |
| Medtronic Vascular, Inc. | $2,184 | 26 | $0 (2020) |
| Abbott Laboratories | $1,483 | 25 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,027 | 65 | $0 (2024) |
| Boston Scientific Corporation | $741.05 | 27 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $695.22 | 51 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $681.50 | 39 | $0 (2024) |
| PFIZER INC. | $627.88 | 38 | $0 (2024) |
| Amgen Inc. | $591.20 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,659 | 119 | Novartis Pharmaceuticals Corporation ($421.64) |
| 2023 | $1,535 | 86 | Janssen Pharmaceuticals, Inc ($183.00) |
| 2022 | $1,655 | 77 | Janssen Pharmaceuticals, Inc ($195.22) |
| 2021 | $1,453 | 79 | Janssen Pharmaceuticals, Inc ($182.56) |
| 2020 | $4,681 | 59 | Novartis Pharmaceuticals Corporation ($3,616) |
| 2019 | $16,315 | 93 | Novartis Pharmaceuticals Corporation ($10,825) |
| 2018 | $22,458 | 100 | Janssen Pharmaceuticals, Inc ($10,189) |
| 2017 | $34,751 | 139 | Novartis Pharmaceuticals Corporation ($21,807) |
All Payment Transactions
752 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/20/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Lithoplasty | ||||||
| 12/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Cardiology | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: DIABETES | ||||||
| 12/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/02/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $65.30 | General |
| Category: CARDIOLOGY | ||||||
| 11/15/2024 | Abbott Laboratories | DIAMONDBACK CORONARY (Device) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Vascular | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.99 | General |
| Category: Cardiovascular | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Obesity | ||||||
| 10/18/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $41.50 | General |
| Category: CARDIOLOGY | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/14/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $24.45 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/10/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/02/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,926 | 4,172 | $1.1M | $225,364 |
| 2022 | 24 | 3,309 | 4,760 | $1.4M | $279,272 |
| 2021 | 25 | 3,254 | 5,223 | $1.6M | $345,588 |
| 2020 | 26 | 3,812 | 5,411 | $1.6M | $322,521 |
Total Patients
13,301
Total Services
19,566
Medicare Billing
$1.2M
Procedure Codes
112
All Medicare Procedures & Services
112 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 514 | 912 | $159,600 | $76,061 | 47.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 185 | 190 | $230,884 | $24,774 | 10.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 72 | 72 | $147,831 | $21,945 | 14.8% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 70 | 140 | $38,780 | $12,716 | 32.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 568 | 1,070 | $99,510 | $10,485 | 10.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 61 | 74 | $16,650 | $9,475 | 56.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 172 | 174 | $156,576 | $8,479 | 5.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 76 | 76 | $23,118 | $8,287 | 35.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 46 | 184 | $20,976 | $7,851 | 37.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 56 | 56 | $21,504 | $7,404 | 34.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 92 | 127 | $18,161 | $6,790 | 37.4% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 35 | 35 | $53,025 | $6,733 | 12.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 35 | 55 | $11,165 | $4,622 | 41.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 569 | 625 | $23,750 | $3,516 | 14.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 73 | 73 | $26,791 | $3,362 | 12.5% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 40 | 42 | $14,154 | $3,259 | 23.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 40 | 41 | $17,425 | $2,312 | 13.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 23 | $7,176 | $2,201 | 30.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $4,584 | $1,650 | 36.0% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 13 | 13 | $6,487 | $1,067 | 16.4% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 13 | 13 | $2,964 | $844.56 | 28.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 43 | 44 | $3,564 | $464.25 | 13.0% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 24 | 24 | $1,560 | $443.39 | 28.4% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 27 | 27 | $2,781 | $256.23 | 9.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 12 | 13 | $1,807 | $247.52 | 13.7% |
About Dr. Alan Blaker, M.D
Dr. Alan Blaker, M.D is a Interventional Cardiology healthcare provider based in Florence, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255399069.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Blaker, M.D has received a total of $85,507 in payments from pharmaceutical and medical device companies, with $2,659 received in 2024. These payments were reported across 752 transactions from 52 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($67,025).
As a Medicare-enrolled provider, Blaker has provided services to 13,301 Medicare beneficiaries, totaling 19,566 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 112 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease
- Location Florence, SC
- Active Since 05/02/2006
- Last Updated 02/01/2021
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1255399069
Products in Payments
- ENTRESTO (Drug) $46,441
- XARELTO (Drug) $25,970
- Resolute (Device) $2,087
- ELIQUIS (Drug) $961.49
- LifeVest (Device) $681.50
- Repatha (Biological) $490.02
- BRILINTA (Drug) $458.24
- NEXLETOL (Drug) $427.13
- LEQVIO (Drug) $423.25
- WATCHMAN Access System (Device) $420.16
- Asahi Fielder coronary guide wire (Device) $414.97
- FLOWTRIEVER CATHETER, S (Device) $331.59
- VITALPATCH RTM (Device) $328.23
- VERQUVO (Drug) $327.93
- FARXIGA (Drug) $312.11
- Mitra Clip system (Device) $294.82
- AMPLATZER Occluders (Device) $290.97
- JARDIANCE (Drug) $245.89
- KENGREAL (Drug) $218.27
- CAMZYOS (Drug) $156.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Florence
Areen Al-Taie, Md, MD
Interventional Cardiology — Payments: $16,493
Interventional Cardiology $16,493
Llewellyn Rowe, Md, MD
Interventional Cardiology — Payments: $4,726
Interventional Cardiology $4,726
Kazim Aykent, Md, MD
Interventional Cardiology — Payments: $4,612
Interventional Cardiology $4,612
James Lee, M.d, M.D
Interventional Cardiology — Payments: $354.34
Interventional Cardiology $354.34
Vitt Leng, Md, MD
Interventional Cardiology — Payments: $18.88
Interventional Cardiology $18.88